- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Douglas Chaet, Discusses Provider Incentives for ACO Model Adoption
According to Douglas Chaet, Senior Vice President, Independence Blue Cross, incentives for providers in accountable care organizations (ACOs) should stem from wanting to get an edge on the competition.
According to Douglas Chaet, Senior Vice President, Independence Blue Cross, incentives for providers in accountable care organizations (ACOs) should stem from wanting to get an edge on the competition.
“It used to be that if you were a highly-compensated physician organization, or well-compensated hospital or health system, you were really in a good place,” Mr Chaet said. However, in an era of transparency, many of those arrangement types may begin work against them.
Mr Chaet argues that ACO type models will allow providers a useful way to get their “toes wet” in performance-based arrangements.
Balancing Cost and Quality in Oncology: A Value-Based Care Perspective
January 30th 2025Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based oncology care can achieve both cost efficiency and high-quality outcomes through integrated multidisciplinary teams, flexible payment models, and targeted treatment approaches.
Read More
Unlocking Access: Exploring Mental Health Care Among Medicaid Managed Care Enrollees
January 23rd 2025On this episode of Managed Care Cast, we speak with the author of a study published in the January 2025 issue of The American Journal of Managed Care® to examine the association between quantitative network adequacy standards and mental health care access among adult Medicaid enrollees.
Listen
Balancing Innovation and Equity in Oncology Value-Based Care: Panel Discussions
January 27th 2025Discussions also delved into the complexities of value-based oncology care, the growing role of real-world data, and strategies to improve access to care in hematology. Across all sessions, a common theme emerged: the need to balance innovation with patient-centered, equitable, and sustainable care models.
Read More
An Argument for Outpatient Bispecific Antibody Delivery: Dr Kirollos Hanna
January 25th 2025Bispecific antibodies have altered the multiple myeloma (MM) treatment landscape, but some practices still lack enough familiarity with these therapeutics to deliver them in outpatient settings.
Read More
